| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |